-
Cagrilintide 10mg
$ 180(0)Cagrilintide | 10mg The next frontier in metabolic science isn't just about suppressing appetite — it's about addressing the hormonal root of why we overeat… -
Semaglutide 10mg
$ 200(0)Semaglutide | 10mg The compound that changed the conversation around metabolic health. Semaglutide is a long-acting GLP-1 receptor agonist developed by Novo Nordisk and one… -
Semaglutide 5mg
$ 100(0)Semaglutide | 5mg The compound that changed the conversation around metabolic health. Semaglutide is a long-acting GLP-1 receptor agonist developed by Novo Nordisk and one… -
Mounjaro 40mg
$ 300(0)Mounjaro (Tirzepatide) | 40mg When it comes to metabolic science, Mounjaro represents a genuine step change. Tirzepatide is the world's first dual GIP and GLP-1… -
Mounjaro 30mg
$ 230(0)Mounjaro (Tirzepatide) | 30mg When it comes to metabolic science, Mounjaro represents a genuine step change. Tirzepatide is the world's first dual GIP and GLP-1… -
Mounjaro 10mg
$ 100(0)Mounjaro (Tirzepatide) | 10mg When it comes to metabolic science, Mounjaro represents a genuine step change. Tirzepatide is the world's first dual GIP and GLP-1… -
-
Retatrutide 50mg
$ 490(0)Retatrutide | 50mg The next generation of metabolic research has arrived. Retatrutide is a groundbreaking triple hormone receptor agonist developed by Eli Lilly that simultaneously… -
Retatrutide 40mg
$ 430(0)Retatrutide | 40mg The next generation of metabolic research has arrived. Retatrutide is a groundbreaking triple hormone receptor agonist developed by Eli Lilly that simultaneously… -
Retatrutide 30mg
$ 360(0)Retatrutide | 30mg The next generation of metabolic research has arrived. Retatrutide is a groundbreaking triple hormone receptor agonist developed by Eli Lilly that simultaneously… -
Retatrutide 20mg
$ 275(0)Retatrutide | 20mg The next generation of metabolic research has arrived. Retatrutide is a groundbreaking triple hormone receptor agonist developed by Eli Lilly that simultaneously… -
Retatrutide 13mg
$ 175(0)Retatrutide | 13mg The next generation of metabolic research has arrived. Retatrutide is a groundbreaking triple hormone receptor agonist developed by Eli Lilly that simultaneously…











